Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Putative upstream-binding factor 1-like protein 6 (UBTFL6) refers to a human gene classified as a pseudogene, meaning it is a DNA segment similar to a functional gene but is not transcribed and translated into a protein under normal conditions. UBTFL6 shares sequence similarity with upstream binding transcription factors involved in RNA polymerase I-mediated transcription but does not appear to encode a functional protein product. Genomic databases and gene annotation resources predict potential activity, such as RNA polymerase I core promoter sequence-specific DNA binding, but there is no experimental evidence that UBTFL6 produces a biologically active protein or participates in disease mechanisms. Accordingly, UBTFL6 is not considered a druggable target and does not serve as a biomarker or safety risk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative upstream-binding factor 1-like protein 6 (UBTFL6).